Question

name five nations of BRICS. what are challenges & target sector before BRICS​

Answer 1

Explanation:

BRICS is the group composed by the five major emerging countries - Brazil, Russia, India, China and South Africa -, which together represent about 42% of the population, 23% of GDP, 30% of the territory and 18% of the global trade.

International skepticism about the BRICS' prospects mainly reflects the slow economic growth, high unemployment rates and severe inflation of Russia, Brazil and South Africa. The economic downturn has also led to an increase in social problems like strikes and crime.

Answer 2

Answer:

BRAZIL, RUSSIA, INDIA, CHINA and SOUTH AFRICA.

The BRICS countries are home to the majority of the global MDR TB patient population but are also engines of economic growth, funding a substantial portion of TB control worldwide.

The BRICS countries could serve as sources of innovative ideas to develop and advance key areas of TB and MDR TB control.

Poverty alleviation programs and free access to health care have helped Brazil keep MDR TB levels relatively low and focus on delivery system innovations such as community-based TB and MDR TB care.

South Africa has made considerable progress in surveillance, infection control, better diagnosis methods, and the rollout of community-based MDR TB treatment, but challenges remain for effectively coordinating the currently siloed HIV and TB programs.

India's national TB control program has the goal of seeking to ensure universal access to quality TB care for its 1.3 billion people in 600 districts. The complexities of TB care coordination across India's public and private sectors, poverty alleviation, active case finding, and treatment of latent TB are key challenges for the future.

Russia has improved TB diagnostic capabilities, the availability of FLDs and SLDs, and infection control programs in recent years. Future steps to further improve the control of DR TB in Russia could include a shift in the TB care paradigm to more outpatient and community-based services, as well as closer integration with the country's HIV program.

Major health care system reforms undertaken in China include reducing the cost of MDR TB treatment for patients and improving the national TB surveillance system to provide individual patients with care as early as possible while generating data to facilitate the management of the disease from a population-based perspective. Opportunities for the future include applying China's strong scientific research capability to better understand the burden of disease and contribute to the development of new drugs to treat MDR TB.